WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹19 Cr | ₹-52 Cr | ₹-198 Cr | ₹-189 Cr | ₹-258 Cr |
What is the latest Net Current Assets ratio of WANBURY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹-52 Cr |
| Mar2023 | ₹-198 Cr |
| Mar2022 | ₹-189 Cr |
| Mar2021 | ₹-258 Cr |
How is Net Current Assets of WANBURY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | Positive | |
| Mar2024 | ₹-52 Cr | Negative | |
| Mar2023 | ₹-198 Cr | Negative | |
| Mar2022 | ₹-189 Cr | Negative | |
| Mar2021 | ₹-258 Cr | - | |
Compare Net Current Assets of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹903.0 Cr | -0.2% | 22.5% | 17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -0.2% |
22.5% |
17.8% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses